Our Technology
Using our combined 30 years experience in asthma and lung research we have developed a revolutionary new way to treat asthma. Harnessing our expertise in airway structure and function, and on a type of tissue-resident stem cell called pericytes, we have devised a whole new category of asthma therapeutic, focusing on the lung structure.
Below we outline the science underpinning our new therapeutic, more information about the drug, and the impact it could have on asthma patients everywhere.
The Science
Learn about the lung structure in asthma and see how targeting a key event in asthma pathology (chemotaxis) can have such a profound effect.
Our Drug
See how our drug works and how we intend for it to be administered.
Potential Impact
Imagine, using our robust data, how patients quality of life will be improved with our therapeutic.